Glass Jacobson Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33K Hold
27
﹤0.01% 538
2026
Q1
$2.44K Hold
27
﹤0.01% 531
2025
Q4
$2.43K Hold
27
﹤0.01% 522
2025
Q3
$2.66K Hold
27
﹤0.01% 520
2025
Q2
$2.46K Hold
27
﹤0.01% 505
2025
Q1
$2.85K Hold
27
﹤0.01% 720
2024
Q4
$2.85K Hold
27
﹤0.01% 720
2024
Q3
$2.92K Hold
27
﹤0.01% 670
2024
Q2
$2.93K Hold
27
﹤0.01% 649
2024
Q1
$3.56K Hold
27
﹤0.01% 644
2023
Q4
$3.29K Sell
27
-6
-18% -$669 ﹤0.01% 618
2023
Q3
$3.7K Sell
33
-2
-6% -$254 ﹤0.01% 588
2023
Q2
$5.1K Buy
+35
New +$4.76K ﹤0.01% 578
2022
Q4
$4.84K Buy
+38
New +$4.41K ﹤0.01% 594

Other funds holding ZBH

Glass Jacobson Investment Advisors's ZBH Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 27 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Glass Jacobson Investment Advisors first reported a position in ZBH in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.1K in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Glass Jacobson Investment Advisors held 27 shares of Zimmer Biomet worth $2.33K as of Q2 2026.
  • Glass Jacobson Investment Advisors left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #538 holding.
  • Glass Jacobson Investment Advisors first reported a position in Zimmer Biomet in Q4 2022 and has held it in 14 quarters since.
  • Glass Jacobson Investment Advisors's Zimmer Biomet position peaked at $5.1K in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.